Site Head of Quality
Kincell Bio
Site Head of Quality
Kincell Bio
Cell therapy CDMO: development, CMC, manufacturing
Kincellis Advanced Therapies is a U.S.-based contract development and manufacturing organization supporting advanced-therapy developers from early-stage CMC, process and analytical development through clinical supply, pivotal-stage programs and commercial supply. With facilities in Gainesville, Florida; Research Triangle Park, North Carolina; and The Woodlands, Texas, Kincellis combines broad technical expertise with flexible, scalable GMP infrastructure across autologous and allogeneic therapies, including but not limited to CAR-T, Tregs, CAR-NK, MSCs, dendritic cell vaccines, exosomes, iPSCs & synthetic mRNA.
For more information, visit our website at www.kincellis.com.
Kincellis Advanced Therapies (formerly Cellipont Bioservices) is seeking a Site Head of Quality to oversee and lead The Woodlands, TX Quality Unit. This individual will serve as the most senior level in The Woodlands, TX Quality unit. This leader will define, govern, and sustain the site quality and compliance strategy required to support clinical and commercial advanced therapy manufacturing in accordance with applicable GMP requirements, regulatory expectations, client commitments, and patient safety obligations.
Reporting to the Chief Quality Officer, the Site Head of Quality will have independent authority and enterprise-level accountability for the site's Quality unit. This role will have oversight of Quality Control, Quality Operations, Quality Systems, Compliance, Validation functions. Including, but not limited to batch disposition governance, inspection readiness, data integrity, and overall quality system performance. The successful candidate will bring the regulatory judgment and operational discipline required to ensure that global GMP expectations are translated into effective, controlled, and inspection-ready site practices.
This leader will reinforce a quality culture that prioritizes patient protection, product quality, data integrity, contamination control, deviation prevention, and timely escalation of significant quality risks, while ensuring that site practices remain aligned with regulatory commitments and sustained compliance expectations.
The Role
The Candidate
#LI-Onsite
Kincellis Advanced Therapies provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable, federal, state, and local laws. Kincellis Advanced Therapies complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.
NOTE TO EMPLOYMENT AGENCIES: Kincellis Advanced Therapies values our relationships with our Recruitment Partners. We will only accept resumes from those partners who have been contracted by a member of our Human Resources team to collaborate with us. We are not responsible for any fees related to resumes that are unsolicited or are received without contract.
Cell therapy CDMO: development, CMC, manufacturing
Kincell Bio is a CDMO that specializes in cell therapies, offering end-to-end development and manufacturing services for early-stage biotech companies and academic spinouts. It provides analytical development, process development, CMC consulting, and GMP manufacturing to advance autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs from research through clinical trials. Led by experienced CDMO executives and supported by investors, it focuses on early-stage partnerships and has expanded capacity with a new RTP facility to scale mid- to late-stage studies. Its goal is to streamline the path from research to clinical trials and commercial production by delivering scalable, high-quality biomanufacturing and development services for the cell-therapy field.
Explore more opportunities at Kincell Bio